ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Protective effects of sinomenine against testicular ischemia/reperfusion injury: Biochemical, histological, and immunohistochemical evidence

Saime Ozbek Sebin, Ayhan Tanyeli, Basak Gulakar, Mustafa Can Guler, Esra Laloglu, Selim Comakli.



Abstract
Download PDF Post

Objective: In testicular ischemia and reperfusion (T/IR) injury, a urological emergency that necessitates immediate intervention and treatment and may result in infertility, the study sought to determine the protective benefits of sinomenine (SIN).
Materials and methods: Thirty male Wistar albino rats were randomly separated into three groups (n=10 per group): sham, T/IR, and T/IR + SIN. Biochemical analyses were performed on testicular homogenates. Rats in the T/IR group experienced reperfusion for two hours after two hours of ischemia. The T/IR+SIN group received an intraperitoneal injection of 10 mg/kg SIN 30 min before reperfusion and underwent the same surgical procedures as those in the T/IR group.
Results: SIN demonstrated anti-inflammatory activity by increasing IL-10 levels while lowering TNF-α, IL-1β, IL-6, NGAL, and NF-κB. SIN also increased levels of antioxidant biomarkers (TAS, GSH, CAT) and decreased the levels of oxidant biomarkers (MDA, MPO, OSI, TOS, NGAL, IMA), exhibiting a protective effect against oxidative stress. Histopathological data showed protection in testicular histoarchitecture by improving epithelial disorganization, severe necrosis in seminiferous tubules, neutrophil infiltration in intertubular areas, severe edema, and hemorrhagic areas. In addition, it had a protective effect on testicular tissue against DNA damage and apoptosis by reducing the levels of 8-OHdG and caspase 3.
Conclusion: Through its antioxidant and anti-inflammatory actions, SIN mitigated T/IR damage by limiting apoptosis and preserving normal testicular tissue structure.

Key words: Testis torsion, ischemia-reperfusion injury, sinomenine, inflammation, apoptosis







Bibliomed Article Statistics

7
R
E
A
D
S

5
D
O
W
N
L
O
A
D
S
03
2026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.